Fibroelastosis Subendocardial Acquired

Fibroelastosis (fibroelasticus) Subendocardial (subendocardialis) Acquired (acquisita) is a condition in which scar changes form in the heart muscle (myocardium). This can be caused by a variety of factors, such as chronic heart conditions such as coronary artery disease or cardiomyopathy, and certain medications such as statins.

Fibroelastosis can manifest as thickening and hardening of the heart muscle, which can impair its function. In some cases, this can lead to heart failure and other serious complications.

Various methods are used to diagnose acquired subendocardial fibroelastosis, including echocardiography, magnetic resonance imaging, and computed tomography. Treatment depends on the cause and severity of the disease.

In general, acquired subendocardial fibroelastosis is a serious disease that requires timely diagnosis and treatment.

*Fibroelastoses* are rare cardiomyopathies of the group of dilated cardiomyopathies, which are characterized by pronounced thickening of the myocardial wall, fibrosis and pronounced hypertrophy of cardiomyocytes. There is an acquired form of fibroelastosis - ***fibroelastosis** subendocardial (subendocardial fibroelastosis) - FSE or congenital - FSD.*

_A distinctive feature of FSE from other cardiomyopathies is the combination of myocardial hypertrophy and pronounced fibrosis of the left ventricular subendocardium_. In this regard, fibrosis of the inner lining of the left ventricle